Tweenvest Stocks

Gubra A/S (CPSE: GUBRA)

Health Care · Life Sciences Tools & Services · DK

Dkr402.40

+8.23% today · +3.3% 1Y

Gubra A/S (CPSE: GUBRA) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $940.74M and employs 300 people.

Over the last twelve months the share price has gained 3.3%, trading between 293.00 and 557.50.

Tweenvest scores Gubra A/S across four factors: quality 69/100, value 40/100, growth 100/100. Its strongest factor is growth.

GUBRA price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$940.74M
Revenue (TTM)
$414.54M
P/E
3.62
EPS
102.70
Dividend yield
Beta (5Y)
0.32
52-week high
Dkr557.50
52-week low
Dkr293.00
Avg volume (3M)
Shares outstanding
16.33M
Employees
300
Next earnings

About Gubra A/S

Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.

ISIN
DK0062266474
Founded
2008
Listed since
Apr 4, 2023
Exchange
OMX Nordic Exchange Copenhagen
Currency
DKK
CompanyMarket capPriceDay
Thermo Fisher Scientific Inc.NYSE: TMO$232.47B$628.15-0.09%
Danaher CorporationNYSE: DHR$151.22B$215.97+0.40%
WuXi AppTec Co., Ltd.SHSE: 603259$69.06BCN¥155.84-4.31%
Samsung Biologics Co.,Ltd.KOSE: A207940$51.75B1,551,000.00+0.19%
Lonza Group AGSWX: LONN$51.21BCHF593.80+1.02%
Agilent Technologies, Inc.NYSE: A$43.33B$154.77+0.87%
IQVIA Holdings Inc.NYSE: IQV$42.84B$259.42-0.32%
Waters CorporationNYSE: WAT$40.36B$414.44+0.90%

Browse every Life Sciences Tools & Services company →

Figures last refreshed Aug 18, 2026.